Executive Summary: Critical Cash Runway
Alvio Labs entered Q1 2026 without the grant income that buoyed Q4 2025, resulting in a net loss of €4,226.52 for the quarter. The absence of revenue during this pre-commercialisation phase, combined with OpEx of €1,194.45, has depleted the cash position to just €116.00 — a 78% decline from the prior year (€532.14 at Mar 2025).
At the current monthly burn rate of approximately €398, this cash balance represents less than one week of operating runway. The business is now entirely dependent on director funding, with €36,247.62 deployed via current and loan accounts — a 141% increase from the prior year.
Immediate liquidity injection or revenue-generating activity is required to extend runway beyond the current critical threshold.
Q4 2025 Performance: Grant-Funded Positive Quarter
Q4 2025 benefited from €12,929.22 in grant income, resulting in a net profit of €2,360.59 despite €5,000 in COGS and €5,568.63 in operating expenses. The grant funding covered 78% of total costs for the period.
Key Q4 spend was international travel (€1,781.07) and consulting/accounting (€2,525.00) — significant investments not repeated at the same scale in Q1 2026.
Net Profit / Loss
Cash Position
Monthly Burn Rate
OpEx / 3 months
Critical: Less than 1 month
Profit & Loss Analysis
Operating Expense Breakdown
P&L Summary
Loss driven by absent grant income vs Q4 2025. Profit driven by €12,929 grant income.
Balance Sheet Position
Liability Structure
Director accounts represent 99.5% of total liabilities
Balance Sheet Summary
Assets
Liabilities
Accumulated losses from prior periods + current year earnings
Trends & Quarter-over-Quarter
Revenue vs Net Profit Trend
Key Metrics Comparison
QoQ Revenue Change
Q4 2025 to Q1 2026
YoY Cash Position
Mar 2025 vs Mar 2026
YoY Liabilities
Director funding increase
OpEff Ratio (Q1)
OpEx/Revenue (pre-revenue)
Required Actions
Immediate Liquidity Injection Required
Current cash of €116.00 provides less than 1 week of runway at €398/month burn rate. Director advance, external funding, or revenue generation required within 7-14 days to avoid payment failures.
Establish Revenue Stream
Q4 2025 grant income of €12,929 was critical to positive performance. Identify and apply for additional grants, or accelerate product commercialisation to generate customer revenue in Q2 2026.
Monitor Director Loan Structure
Director funding now totals €36,247.62 (loan + current accounts). Document loan terms formally to ensure capital protection and clear repayment priority vs. future external debt.